- Home
- PHGE vs ILAG Comparison
PHGE vs ILAG Comparison
Compare PHGE & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- ILAG
- Stock Information
- Founded
- PHGE 2015
- ILAG 1981
- Country
- PHGE Israel
- ILAG Hong Kong
- Employees
- PHGE N/A
- ILAG N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- ILAG Office Equipment/Supplies/Services
- Sector
- PHGE Health Care
- ILAG Consumer Discretionary
- Exchange
- PHGE Nasdaq
- ILAG Nasdaq
- Market Cap
- PHGE 12.6M
- ILAG 11.1M
- IPO Year
- PHGE N/A
- ILAG 2022
- Fundamental
- Price
- PHGE $0.48
- ILAG $0.66
- Analyst Decision
- PHGE Strong Buy
- ILAG
- Analyst Count
- PHGE 1
- ILAG 0
- Target Price
- PHGE $15.00
- ILAG N/A
- AVG Volume (30 Days)
- PHGE 389.8K
- ILAG 719.1K
- Earning Date
- PHGE 11-13-2025
- ILAG 04-28-2025
- Dividend Yield
- PHGE N/A
- ILAG N/A
- EPS Growth
- PHGE N/A
- ILAG N/A
- EPS
- PHGE N/A
- ILAG N/A
- Revenue
- PHGE N/A
- ILAG $7,506,551.00
- Revenue This Year
- PHGE N/A
- ILAG N/A
- Revenue Next Year
- PHGE N/A
- ILAG N/A
- P/E Ratio
- PHGE N/A
- ILAG N/A
- Revenue Growth
- PHGE N/A
- ILAG 16.50
- 52 Week Low
- PHGE $0.34
- ILAG $0.34
- 52 Week High
- PHGE $1.16
- ILAG $1.20
- Technical
- Relative Strength Index (RSI)
- PHGE 50.36
- ILAG 56.76
- Support Level
- PHGE N/A
- ILAG $0.60
- Resistance Level
- PHGE $0.51
- ILAG $0.96
- Average True Range (ATR)
- PHGE 0.03
- ILAG 0.08
- MACD
- PHGE -0.03
- ILAG 0.01
- Stochastic Oscillator
- PHGE 85.12
- ILAG 38.50
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.